Mon, Jul 28, 2014, 5:18 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Exelixis, Inc. Message Board

  • w.capron w.capron Dec 4, 2012 7:31 AM Flag

    U.S Court rules cannot prosecute for Off-Lable sales

    Under PFE news-Fly on the wall

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The title is a bit misleading. Off label sales are not illegal. At question is off label promotion by company sales reps. The ruling looks narrow intitially and covers the truthful verbal discussion of a drug's off label use by a sales rep on an office call. In this particular case the rep was responding to questions asked by an undercover agent. Unclear is whether this will extend to other promotional material such as advertising to clinicians and the public.

      • 2 Replies to erniewerner
      • reps can't discuss anything off-label even if asked. They cannot talk about p2 trials, p3 trials, potential indications, etc... Off-label use by a physician is completely legal however. Insurance will usually stop a product from being used if it is not for the approved indication so the physician would have to say it is being used for the approved indication for the patients insurance to reimburse.

      • This court ruling remains in a grey area and may be headed to the Supreme Court. FDA will certainly object as will the Justice Dept. Companies cannot deviate from the package insert in their promotional materials. However, salesmen who are trained about the pipeline of additional indications may be speak about them. Perhaps they can refer to third party publications on phase 2 trials. What is termed "legal" is whether the drug is approved or not, rather than approval for a specific indication. This was a test case set up by the pharmaceutical industry who are tired of paying hefty fines for what has become a normal and customary practice.

        Sentiment: Buy

 
EXEL
4.40+0.21(+5.01%)Jul 28 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.